3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity

Brain Research

Volumn 1039, Issue 1-2, 2005, Pages 97-107

  Williams, Michael T ^a   Schaefer, Tori L ^a   Ehrman, Lisa A ^a   Able, Jessica A ^a   Gudelsky, Gary A ^b   Sah, Renu ^a   Vorhees, Charles V ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

5 HIAA; 5 HT; 3H paroxetine binding; ACTH; Corticosterone; DOPAC; Dopamine; Ecstasy; Hippocampus; MDMA; Neostriatum; Serotonin transporter; Thymus

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BRAIN MONOAMINE; CORTICOSTERONE; CORTICOTROPIN; DOPAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; EXAMINATION; FEMALE; HIPPOCAMPUS; HYPOPHYSIS ADRENAL SYSTEM; LEARNING DISORDER; LONG TERM EXPOSURE; MALE; MENTAL STRESS; METABOLITE; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; NEUROTOXICITY; NONHUMAN; OBSERVATION; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; STRIATE CORTEX;

EID: 15144362179     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.01.045     Document Type: Article

References (68)

1. 1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids J. Neurochem. 68 1997 1099 1105
2. N. Aguirre, M. Barrionuevo, B. Lasheras, and J. Del Río The role of dopaminergic systems in the perinatal sensitivity to 3,4- methylenedioxymethamphetamine-induced neurotoxicity in rats J. Pharmacol. Exp. Ther. 286 1998 1159 1165
3. M.H. Andrews, and S.G. Matthews Programming of the hypothalamo-pituitary- adrenal axis: serotonergic involvement Stress 7 2004 15 27
4. E.C. Azmitia Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis Brain Res. Bull. 56 2001 413 424
5. J.M. Bakker, A. Kavelaars, C.J. Heijnen, F.J.H. Tilders, and E.P. van Rees Effects of neonatal dexamethasone treatment on hypothalamo-pituitary adrenal axis and immune system of the rat J. Neuroimmunol. 74 1997 69 76
6. G. Battaglia, S.Y. Yeh, E. O'Hearn, M.E. Molliver, M.J. Kuhar, and E.B. De Souza 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites J. Pharmacol. Exp. Ther. 242 1987 911 916
7. S.A. Bayer, J. Altman, R.J. Russo, and X. Zhang Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat Neurotoxicology 14 1993 83 144
8. H.W. Broening, L. Bacon, and W. Slikker Jr. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4- methylenedioxymethamphetamine J. Pharmacol. Exp. Ther. 271 1994 285 293
9. H.W. Broening, J.F. Bowyer, and W. Slikker Jr. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response J. Pharmacol. Exp. Ther. 275 1995 325 333
10. H.W. Broening, L.L. Morford, S.L. Inman-Wood, M. Fukumura, and C.V. Vorhees 3,4-Methylenedioxymethamphetamine (Ecstasy)-induced learning and memory impairments depend on the age of exposure during early development J. Neurosci. 21 2001 3228 3235
11. J. Cami, M. Farre, M. Mas, P.N. Roset, S. Poudevida, A. Mas, L. San, and T.R. de la Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects J. Clin. Psychopharmacol. 20 2000 455 466
12. T.J. Connor, M.G. McNamara, D. Finn, A. Currid, M. O'Malley, A.M. Redmond, J.P. Kelly, and B.E. Leonard Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat Immunopharmacology 38 1998 253 260
13. E.R. de Kloet, E. Vreugdenhil, M.S. Oitzl, and M. Joδls Brain corticosteroid receptor balance in health and disease Endocr. Rev. 19 1998 269 301
14. T.R. de la, and M. Farre Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans Trends Pharmacol. Sci. 25 2004 505 508
15. T.R. de la, M. Farre, J. Ortuno, M. Mas, R. Brenneisen, P.N. Roset, J. Segura, and J. Cami Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br. J Clin. Pharmacol. 49 2000 104 109
16. F. Fernandez, S. Aguerre, P. Mormede, and F. Chaouloff Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats Eur. J. Neurosci. 16 2002 607 618
17. E. Gould, C.S. Woolley, H.A. Cameron, D.C. Daniels, and B.S. McEwen Adrenal steroids regulate postnatal development of the rat dentate gyrus: II. Effects of glucocorticoids and mineralocorticoids on cell birth J. Comp. Neurol. 313 1991 486 493
18. E. Gould, C.S. Woolley, and B.S. McEwen Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death J. Comp. Neurol. 313 1991 479 485
19. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol. Rev. 55 2003 463 508
20. C.S. Grob, R.E. Poland, L. Chang, and T. Ernst Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations Behav. Brain Res. 73 1996 103 107
21. L.J. Grota Serotonin regulation of corticoid secretion in infant rats Dev. Psychobiol. 14 1981 221 228
22. H. Hayakawa, Y. Okamoto, M. Shimizu, A. Nishida, N. Motohashi, and S. Yamawaki Single or repeated treatment with electroconvulsive shock increases number of serotonin uptake binding sites in the frontal cortex Neuropsychobiology 31 1995 1 5
23. E. Ho, L. Karimi-Tabesh, and G. Koren Characteristics of pregnant women who use Ecstasy (3,4-methylenedioxymethamphetamine) Neurotoxicol. Teratol. 23 2001 561 567
24. Y.J. Ho, C.R. Pawlak, L. Guo, and R.K. Schwarting Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat Behav. Brain Res. 149 2004 135 144
25. G. Iaria, M. Petrides, A. Dagher, B. Pike, and V.D. Bohbot Cognitive strategies dependent on the hippocampus and caudate nucleus in human navigation: variability and change with practice J. Neurosci. 23 2003 5945 5952
26. T. Inomata, and T. Nakamura Influence of adrenalectomy on the development of the neonatal thymus in the rat Biol. Neonate 55 1989 238 243
27. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg Monitoring the future national survey results on drug abuse, 1975-2003 Vol. I Secondary school students NIH Publication 04-5507 2004 National Institue on Drug Abuse Bethesda, MD
28. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg Monitoring the future national survey results on drug abuse, 1975-2003 Vol. II College students and adult ages 19-45 NIH Publication vol. 04-5508 2004 National Institue on Drug Abuse Bethesda, MD
29. P.A. Kelly, I.M. Ritchie, L. Quate, D.E. McBean, and H.J. Olverman Functional consequences of perinatal exposure to 3,4- methylenedioxymethamphetamine in rat brain Br. J. Pharmacol. 137 2002 963 970
30. N. Kioukia-Fougia, K. Antoniou, S. Bekris, C. Liapi, I. Christofidis, and Z. Padadopoulou-Daifoti The effects of stress exposure on the hypothalamic-pituitary-adrenal axis, thymus, thyroid hormones and glucose levels Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 823 830
31. R.E. Kirk Experimental design: procedures for the behavioral sciences 1995 Brooks/Cole Publishing Pacific Grove
32. J.B. Koprich, N.G. Campbell, and J.W. Lipton Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat Brain Res. Dev. Brain Res. 147 2003 177 182
33. H. Liu, J. Kaur, K. Dashtipour, R. Kinyamu, C.E. Ribak, and L.K. Friedman Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level Exp. Neurol. 184 2003 196 213
34. S.J. Lupien, and B.S. McEwen The acute effects of corticosteroids on cognition: integration of animal and human model studies Brain Res. Rev. 24 1997 1 27
35. S.J. Lupien, and M. Lepage Stress, memory, and the hippocampus: can't live with it, can't live without it Behav. Brain Res. 127 2001 137 158
36. M. Mas, M. Farré, R. de la Torre, P.N. Roset, J. Ortuño, J. Segura, and J. Cami Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans J. Pharmacol. Exp. Ther. 290 1999 136 145
37. C. Mazer, J. Muneyyirci, K. Taheny, N. Raio, A. Borella, and P. Whitaker-Azmitia Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits Brain Res. 760 1997 68 73
38. P.R. McElhatton, D.N. Baterman, C. Evans, K.R. Pughe, and S.H. Thomas Congenital anomalies after prenatal ecstasy exposure Lancet 354 1999 1441 1442
39. J.S. Meyer, and S.F. Ali Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain Ann. N. Y. Acad. Sci. 965 2002 373 380
40. J.S. Meyer, M. Grande, K. Johnson, and S.F. Ali Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats Int. J. Dev. Neurosci. 22 2004 261 271
41. K.C. Morley, J.E. Gallate, G.E. Hunt, P.E. Mallet, and I.S. McGregor Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("Ecstasy") Eur. J. Pharmacol. 433 2001 91 99
42. J.F. Nash Jr., H.Y. Meltzer, and G.A. Gudelsky Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine J. Pharmacol. Exp. Ther. 245 1988 873 879
43. M. Navarro, S. Pichini, M. Farre, J. Ortuno, P.N. Roset, J. Segura, and T.R. de la Usefulness of saliva for measurement of 3,4- methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH Clin. Chem. 47 2001 1788 1795
44. R. Pacifici, P. Zuccaro, C.H. Lopez, S. Pichini, S. di Carlo, M. Farre, P.N. Roset, J. Ortuño, J. Segura, and R.L. Torre Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans J. Pharmacol. Exp. Ther. 296 2001 207 215
45. A.C. Parrott Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity Pharmacology, Biochemistry and Behavior 71 2002 837 844
46. F. Pollier, S. Sarre, S. Aguerre, G. Ebinger, P. Mormede, Y. Michotte, and F. Chaouloff Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality Neuropsychopharmacology 22 2000 64 76
47. D. Pubill, A.M. Canudas, M. Pallas, A. Camins, J. Camarasa, and E. Escubedo Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2003 490 499
48. K.W. Raines, F.J. Seidler, and T.A. Slotkin Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos Brain Res. Dev. Brain Res. 130 2001 65 72
49. D. Rice, and S. Barone Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models Environ. Health Perspect. 108 2000 511 533
50. G.A. Richardson, S.C. Hamel, L. Goldschmidt, and N.L. Day Growth of infants prenatally exposed to cocaine/crack: comparison of prenatal care and no prenatal care sample Pediatrics 104 1999 e18
51. R.M. Sapolsky, and M.J. Meaney Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period Brain Res. Rev. 11 1986 65 76
52. J.E. Sprague, A.S. Preston, M. Leifheit, and B. Woodside Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning Physiol. Behav. 79 2003 281 287
53. C.J. Teter, and S.K. Guthrie A comprehensive review of MDMA and GHB: two common club drugs Pharmacotherapy 21 2001 1486 1513
54. D.M. Vázquez Stress and the developing limbic-hypothalamic- pituitary-adrenal axis Psychoneuroendocrinology 23 1998 663 700
55. C.V. Vorhees Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins Drug Chem. Toxicol. 20 1997 387 399
56. C.V. Vorhees, S.L. Inman-Wood, L.L. Morford, H.W. Broening, M. Fukumura, and M.S. Moran Adult learning deficits after neonatal exposure to d-methamphetamine: selective effects on spatial navigation and memory J. Neurosci. 20 2000 4732 4739
57. C.V. Vorhees, T.M. Reed, M.R. Skelton, and M.T. Williams Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning Int. J. Dev. Neurosci. 22 2004 247 259
58. I.Q. Whishaw, G. Mittleman, S.T. Bunch, and S.B. Dunnett Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesions in rats Behav. Brain Res. 24 1987 125 138
59. P.M. Whitaker-Azmitia, M. Druse, P. Walker, and J.M. Lauder Serotonin as a developmental signal Behav. Brain Res. 73 1996 19 29
60. N.M. White, and R.J. McDonald Multiple parallel memory systems in the brain of the rat Neurobiol. Learn. Mem. 77 2002 125 184
61. M.T. Williams, T.L. Blankenmeyer, T.L. Schaefer, C.A. Brown, G.A. Gudelsky, and C.V. Vorhees Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood Dev. Brain Res. 147 2003 163 175
62. M.T. Williams, L.L. Morford, S.L. Wood, S.L. Rock, A.E. McCrea, M. Fukumura, T.L. Wallace, H.W. Broening, M.S. Moran, and C.V. Vorhees Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress Brain Res. 968 2003 89 101
63. M.T. Williams, C.A. Brown, M.R. Skelton, A.A. Vinks, and C.V. Vorhees Absorption and clearance of +/-3,4-methylenedioxymethamphetamine from the plasma of neonatal rats Neurotoxicol. Teratol. 26 2004 849 856
64. J.T. Winslow, and T.R. Insel Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine J. Pharmacol. Exp. Ther. 254 1990 212 220
65. C.S. Woolley, E. Gould, and B.S. McEwen Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons Brain Res. 531 1990 225 231
66. W. Yan, C.C. Wilson, and J.H. Haring 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells Brain Res. Dev. Brain Res. 98 1997 185 190
67. W. Yan, C.C. Wilson, and J.H. Haring Effects of neonatal serotonin depletion on the development of rat dentate granule cells Brain Res. Dev. Brain Res. 98 1997 177 184
68. J.L.W. Yau, J. Noble, and J.R. Seckl Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: role of corticosterone and serotonin Neuroscience 78 1997 111 121